Novelstem International Corp NSTM:OTCPK

RT Quote | Exchange | USD
Last | 05/19/22 EDT
0.28UNCH (UNCH)
52 week range
0.03 - 0.35
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.28
  • 52 Week High0.35
  • 52 Week High Date07/02/21
  • 52 Week Low0.03
  • 52 Week Low Date12/31/21

Key Stats

  • Market Cap13.13M
  • Shares Out46.88M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.39
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.28
  • 52 Week High0.35
  • 52 Week High Date07/02/21
  • 52 Week Low0.03
  • 52 Week Low Date12/31/21
  • Market Cap13.13M
  • Shares Out46.88M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.39
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.28
  • P/E (TTM)1.02
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.814M
  • ROE (TTM)22.72%
  • Revenue (TTM)420,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)1,472.12%
  • Debt To Equity (MRQ)0.11%

EVENTS

  • Earnings Date-
  • Ex Div Date03/22/2018
  • Div Amount0.45
  • Split Date-
  • Split Factor-

Latest On Novelstem International Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
NovelStem International Corp. is primarily focused on the development and commercialization of diagnostic technology. The Company predicts patients’ anti-cancer drug resistance, which allows targeted cancer treatments and the potential to reduce resistance to chemotherapy.
Jan Loeb
Chairman of the Board
Address
2255 Glades Road, Suite 221A
Boca Raton, FL
33431
United States